Who
Kemal Malik
Director
Company insider
Files Form 4 as: Director, Cartesian Therapeutics; Director, Acceleron Pharma.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 2 Jan 2020
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,600 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,600 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,600 at $0.00 | filing |
| 1 Jul 2024filed 3 Jul 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,600 at $0.00 | filing |
| 1 Jul 2024filed 3 Jul 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,933 at $0.00 | filing |
| 19 Nov 2021filed 22 Nov 2021 | Acceleron Pharmaoption or derivative | SEC FORM 4 Code D | —17,956 | filing |
| 19 Nov 2021filed 22 Nov 2021 | Acceleron Pharmaoption or derivative | SEC FORM 4 Code D | —3,222 | filing |
| 19 Nov 2021filed 22 Nov 2021 | Acceleron Pharma | SEC FORM 4 Code U | —1,622 | filing |
| 29 Jan 2021filed 2 Feb 2021 | Acceleron Pharma | SEC FORM 4 Code A | —1,622 at $0.00 | filing |
| 29 Jan 2021filed 2 Feb 2021 | Acceleron Pharmaoption or derivative | SEC FORM 4 Code A | —3,222 at $0.00 | filing |
| 2 Jan 2020filed 10 Feb 2020 | Acceleron Pharmaoption or derivative | SEC FORM 4 Code A | —17,956 at $0.00 | filing |
| 2 Jan 2020filed 3 Jan 2020 | Acceleron Pharmaoption or derivative | SEC FORM 4 Code A | —17,567 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.